GOLDMAN SACHS GROUP INC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,582,101
-41.4%
594,589
-14.2%
0.00%
-50.0%
Q2 2023$11,231,293
-22.5%
692,862
-20.4%
0.00%
-33.3%
Q1 2023$14,485,267
+1833.0%
869,986
+991.3%
0.00%
Q4 2022$749,368
+641.9%
79,720
+115.3%
0.00%
Q3 2022$101,000
-39.2%
37,035
-35.4%
0.00%
Q2 2022$166,000
-78.7%
57,357
-78.0%
0.00%
Q1 2022$781,000
+95.2%
260,349
+199.3%
0.00%
Q4 2021$400,000
-54.7%
86,997
-38.1%
0.00%
Q3 2021$883,000
-49.5%
140,611
-51.8%
0.00%
Q2 2021$1,749,000
+464.2%
291,981
+495.4%
0.00%
Q1 2021$310,000
-29.2%
49,043
-36.9%
0.00%
Q4 2020$438,000
-88.0%
77,770
-87.6%
0.00%
-100.0%
Q3 2020$3,638,000
-12.4%
625,024
+8.5%
0.00%0.0%
Q2 2020$4,154,000
+967.9%
576,154
+592.6%
0.00%
Q1 2020$389,000
-66.0%
83,189
-41.7%
0.00%
Q4 2019$1,145,000
+74.3%
142,755
+49.4%
0.00%
Q3 2019$657,000
+170.4%
95,542
+226.7%
0.00%
Q2 2019$243,000
-62.5%
29,244
-55.1%
0.00%
Q1 2019$648,000
-61.6%
65,195
-70.4%
0.00%
-100.0%
Q4 2018$1,687,000
-7.5%
220,448
+110.5%
0.00%
Q3 2018$1,824,000
+67.0%
104,739
-9.0%
0.00%
Q2 2018$1,092,000
+18.2%
115,096
-45.6%
0.00%
Q1 2018$924,000
+2540.0%
211,429
+623.1%
0.00%
Q4 2016$35,000
-20.5%
29,239
+128.0%
0.00%
Q4 2015$44,000
-58.9%
12,826
-29.8%
0.00%
Q3 2015$107,000
-36.7%
18,262
-22.9%
0.00%
Q2 2015$169,00023,6940.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders